Skip to main content

Find Clinical Trials

Home
Conditions
Lysosomal Storage Diseases

Clinical trial condition

Lysosomal Storage Diseases

Explore clinical trials studying Lysosomal Storage Diseases. Study availability and eligibility vary by location and protocol.

717 public trials 126 recruiting studies

Refine in advanced search Browse all conditions

Lysosomal Storage Diseases trial results

Completed

Fabry : National Initiative of Screening

NCT00484549

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
Locations: Hôpital Gabriel Montpied Clermont-Ferrand, France

View Trial Details

Completed

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

NCT00048711

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Completed

A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease

NCT00515398

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations: University of Florida Gainesville, Florida, United States

Washington University St Louis, Missouri, United States

Center for Metabolic Disorders Lake Success, New York, United States

Duke University Durham, North Carolina, United States

View Trial Details

Completed

Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses

NCT00672022

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Genetic and Family Studies of Inherited Muscle Diseases

NCT00001331

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +24 more
Locations: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States

View Trial Details

Completed

Alternative Dosing and Regimen of Replagal to Treat Fabry Disease

NCT00075244

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease

NCT00071877

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +27 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Data Collection in Women With Fabry Disease

NCT00030134

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

PET Scan of Brain Metabolism in Relation to Age and Disease

NCT00001972

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +32 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Replagal Enzyme Replacement Therapy for Adults With Fabry Disease

NCT00097890

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details